GE Healthcare's $2.3 Billion Takeover Is a Bold Growth Play. Here's Why. -- Barrons.com

Dow Jones
2025/11/22

Al Root

GE Healthcare Technologies is trying to kick-start growth, which should please investors.

The medical imaging and diagnostic company announced on Thursday an agreement to acquire Intelerad, a medical imaging software provider with a presence in outpatient ambulatory care, for $2.3 billion in cash.

The deal should close in the first half of 2026.

The deal complements GE HealthCare's inpatient footprint. "The combined business will broaden customer reach and [deliver] a comprehensive, integrated imaging solution across multiple care settings," said the company in a news release. "In addition, Intelerad's business model accelerates GE HealthCare's shift towards a [software as a service], SaaS, model and significantly increases recurring revenue."

It is GE Healthcare's first acquisition since its separation from GE in January 2023, pointed out Citi analyst Joanne Wuensch in a Thursday report. "The transaction will be immediately accretive to top-line growth and adjusted [operating profit] margin, though slightly dilutive to adjusted earnings per share in the short term," she said. Wuensch rates GE Healthcare stock Hold and has an $83 price target for shares.

Revenue in the first full year of ownership should be about $270 million, said the company. Earnings before interest, taxes, depreciation, and amortization, or Ebitda, margins are "in excess of 30%." GE Healthcare is expected to produce a 2025 Ebitda margin of almost 18% from sales of about $20.5 billion.

Investors don't seem to mind the dilution. Shares rose 2.3% on Friday, closing at $76.45, while the S&P 500 and Dow Jones Industrial Average gained 1% and 1.1%, respectively. Friday's gain for GE Healthcare stock followed a 3.4% jump on Thursday.

Coming into Friday trading, GE Healthcare's stock was down 4% so far this year and down 12% over the past 12 months.

Tariffs and trade concerns have weighed on investor sentiment and on Wall Street's forecasts of profits. GE Healthcare is expected to make about $4.55 per share in 2025. That estimate was closer to $4.70 a year ago.

GE Healthcare earned about $4.50 in 2024, so earnings growth has been slow lately.

Write to Al Root at allen.root@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 21, 2025 16:19 ET (21:19 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10